A 54-year-old diabetic man presented to the hospital with shock and bradycardia. His initial estimated left ventricular ejection fraction (LVEF) was 15% and the electrocardiogram showed a junctional escape rhythm with a wide QRS complex and no P wave. Intensive supportive therapy was initiated after inserting a pacemaker and starting extracorporeal membrane oxygenation. A myocardial biopsy confirmed acute lymphocytic myocarditis with extensive myocyte necrosis, and cardiac transplantation was planned. However, the patient survived without transplantation after vigorous hemodynamic support for 2 weeks. After discharge, he had limited activity for 4 months due to dyspnea caused by a reduced systolic heart function (LVEF, 21%) with a junctional escaped beat. His systolic function recovered markedly 6 months after stopping the hemodynamic support, with the presence of a P wave and narrowed QRS complex. (Korean J Med 2015;89:439-443) 
INTRODUCTION
A reported patient with viral fulminant myocarditis was admitted with seriously impaired cardiac function requiring aggressive hemodynamic support and discharged after several weeks with markedly improved systolic function [1] . After surviving the acute unstable period, the long-term outcome of this disease is excellent [2] . Heart transplantation is occasionally required if the patient does not recover from the acute period; otherwise, activity is limited post-recovery. The optimal recovery time for a successful outcome in patients with fulminant myocarditis is the early period after presentation. We treated a 
CASE REPORT
A 54-year-old man whose body mass index was 26. 
DISCUSSION
Fulminant myocarditis is life-threatening in its acute phase due to markedly decreased cardiac function. However, recovery is often complete after the early decompensated phase, and if the patient survives the acute active phase without complications, the long-term prognosis is excellent [2] . Recently, a venoarterial ECMO device, which is widely used for cardiogenic shock and cardiac arrest, has been introduced for the treatment of fulminant myocarditis. It is a more accessible and involves a reversible approach compared with left ventricular assist devices [4] . In a recent meta-analysis, more than two-thirds of the patients presenting with shock or arrest survived with ECMO support [5] .
While immunosuppression has no known effective role in acute myocarditis, potent hemodynamic support is a standard treatment for acute fulminant myocarditis with hemodynamic compromise [6] .
Most patients with acute active myocarditis have early, spontaneously improved cardiac function post-presentation; typically, hemodynamic support with ECMO is required for approximately 1 week, unlike our case. The median duration of ECMO support in most cases is 5 to 7 days [7] .
Our patient eventually showed delayed improvement of car- Various ECG changes, including ST-segment and T-wave abnormalities, have been reported in fulminant myocarditis, with serious conduction disturbances associated with more severe histological myocardial necrosis and poorer prognoses [8] . Abnormal QRS complexes have more severe clinical courses and a higher mortality rate. A recent study reported that prolonged QRS duration is an independent predictor of cardiac death and the need for heart transplantation [9] . However, the ECG changes were evaluated at specific time points during hospitalization, and ECG changes in fulminant myocarditis could present any time after admission [9] . In this case, the QRS was prolonged before recovery, but subsequently narrowed with improvements in cardiac function. Therefore, ECG changes are a possible indicator of myocardial disease status. Generally, ECG abnormalities improve after the acute phase. Lee et al. [10] reported the reversal of various ECG changes in a patient within 7 days. A wide QRS was also observed in our case; however, contrary to Lee et al. [10] , ECG changes, including the presence of a P wave and shortening of the QRS duration, were observed much later (6 months after stopping ECMO support, Fig. 2C ). The treatment for arrhythmic complications during myocarditis is predominantly supportive; if arrhythmias persist after the recovery of left ventricular function, they are treated accordingly.
In conclusion, we cautiously suggest that close observation is possible for up to half a year before considering cardiac transplantation for fulminant myocarditis patients who are hemodynamically stable after ECMO cessation.
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